SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,775.00    80.00 (1.19%)
Bid:
6,770.00
Ask:
6,780.00
Spread: 10.00 (0.148%)
Market Cap: £5.00b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Trading update

6 Jul 2010 07:00

RNS Number : 8527O
Spirax-Sarco Engineering PLC
06 July 2010
 



 

Spirax-Sarco Engineering plc

Tuesday 6th July 2010

 

TRADING UPDATE

 

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following update in respect of its trading for the six months ended 30th June 2010. Results for the first half-year are expected to be announced on 24th August 2010.

 

Since the AGM, trading conditions continue to be positive and sales for the first half-year were ahead 8% at constant currency, including a 2% contribution from acquisitions; also, the order book increased. Growth continues to be led by Watson-Marlow Pumps and in the steam business by the Americas and Asia Pacific, with EMEA mixed but overall flat. Exchange movements have been favourable and added 2% to sales on translation in the first half-year versus average exchange rates in the comparable period last year.

 

Adjusted operating profit margin1 shows a strong improvement over the 15.0% in the first half of 2009 and is expected to be above 19% for the first half of 2010. We have benefited from operational gearing from the increase in sales, last year's cost reduction measures, small exchange gains and a favourable product mix. Material costs have also been favourable but are rising and we anticipate this impacting the second half of the year. We are also increasing our investment in new product development and in market development to enhance our future growth prospects.

 

We continue to operate with a strong balance sheet and net cash balances at 30th June 2010 were £18m. As we have previously indicated, capital investment for this year is expected to be at a high level as we progress several major manufacturing projects, including our new plant in China that was opened last week and the consolidation onto one manufacturing site in Cheltenham.

 

 

1 The adjusted operating profit margin noted above excludes the amortisation of acquisition-related intangible assets and an £8m exceptional revaluation gain following the 25th May 2010 acquisition of our partners' 51% shareholding in our Mexican business.

 

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,200 people, of whom 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKPDBABKDBOK
Date   Source Headline
21st Jul 201510:18 amRNSListing Application
21st Jul 20158:41 amRNSDirector/PDMR Shareholding
9th Jul 20153:22 pmRNSNotice of Results
2nd Jul 201510:00 amRNSAcquisition
19th Jun 20153:00 pmRNSHolding(s) in Company
18th Jun 20153:30 pmRNSDirector/PDMR Shareholding
18th Jun 201512:22 pmRNSHolding(s) in Company
18th Jun 201511:48 amRNSHolding(s) in Company
12th Jun 20153:50 pmRNSShare Consolidation
11th Jun 201512:37 pmRNSAmendment to Official List & Share Consolidation
10th Jun 20153:55 pmRNSAdditional Listing
9th Jun 20153:54 pmRNSAdditional Listing
2nd Jun 20153:56 pmRNSDirector/PDMR Shareholding
11th May 20155:00 pmRNSResult of AGM
11th May 20157:00 amRNSAGM Statement
1st May 20154:27 pmRNSDirector/PDMR Shareholding
1st May 20154:11 pmRNSNotification of Release Date
23rd Apr 20155:56 pmRNSHolding(s) in Company
21st Apr 20153:51 pmRNSDirector/PDMR Shareholding
21st Apr 20157:00 amRNSQueen's Award for Enterprise
9th Apr 20158:34 amRNSAcquisition
30th Mar 20155:05 pmRNSDirector/PDMR Shareholding
11th Mar 20154:29 pmRNSDirector/PDMR Shareholding
5th Mar 20157:01 amRNSSpirax Sarco to start direct operations in India
5th Mar 20157:00 amRNS2014 Preliminary Results
13th Jan 20154:12 pmRNSHolding(s) in Company
13th Jan 20154:11 pmRNSTotal Voting Rights
2nd Dec 201410:34 amRNSDirector/PDMR Shareholding
18th Nov 20144:08 pmRNSHolding(s) in Company
18th Nov 20144:07 pmRNSHolding(s) in Company
12th Nov 20144:41 pmRNSDirector/PDMR Shareholding
7th Nov 20147:00 amRNSInterim Management Statement
4th Nov 20144:13 pmRNSTotal Voting Rights
4th Nov 20144:13 pmRNSHolding(s) in Company
13th Oct 20144:59 pmRNSDirector/PDMR Shareholding
6th Oct 201411:57 amRNSTotal Voting Rights
1st Oct 201410:00 amRNSNotification of Key Date
22nd Sep 20145:15 pmRNSDirector/PDMR Shareholding
10th Sep 20147:00 amRNSCET signs Heads of Terms with Spirax Sarco
4th Sep 20143:31 pmRNSTotal Voting Rights
28th Aug 20144:25 pmRNSHolding(s) in Company
19th Aug 20144:14 pmRNSDirector/PDMR Shareholding
7th Aug 20147:00 amRNSHalf Yearly Report
6th Aug 20142:13 pmRNSTotal Voting Rights
25th Jul 20142:05 pmRNSHolding(s) in Company
7th Jul 20143:25 pmRNSNotification of Key Dates
2nd Jul 20143:43 pmRNSTotal Voting Rights
25th Jun 20143:05 pmRNSHolding(s) in Company
23rd Jun 20148:49 amRNSHolding(s) in Company
12th Jun 20148:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.